Search results
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoImage source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024,...
AstraZeneca, Sanofi Bolt Higher On Quarterly Beats, But Bristol Myers Dives
Investor's Business Daily· 2 hours agoThe Cambridge U.K.-based drugmaker reported almost $5.11 billion in sales of its cancer drugs. Sales...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 1 hour agoAstraZeneca PLC (AZN, Financial) has recently seen a notable uptick in its stock performance, with a market capitalization now standing at a robust $231.04 billion. Over the ...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 4 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 6 hours agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 7 hours agoAstraZeneca revealed soaring sales over the latest quarter as it was boosted by its cancer drugs....
AstraZeneca Earnings, Sales Rise, Beat Forecasts
The Wall Street Journal· 10 hours agoHEALTH AstraZeneca posted increased first-quarter core earnings per share and sales that beat forecasts. The Anglo-Swedish pharmaceutical giant said...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 5 hours agoAstraZeneca’s revenue and profits grew at a rapid clip over the first three months of the year,...
AstraZeneca overtakes Shell as Britain’s most valuable company By Proactive Investors
Investing.com· 9 hours agoAstraZeneca PLC (LON:AZN)’s solid rally following Thursday’s first-quarter earnings print has made...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 13 hours agoAstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu.